These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 19403663)

  • 41. Bivalent VSV Vectors Mediate Rapid and Potent Protection from Andes Virus Challenge in Hamsters.
    Marceau J; Safronetz D; Martellaro C; Marzi A; Rosenke K; Feldmann H
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Construction and evaluation of DNA vaccine encoding Hantavirus glycoprotein N-terminal fused with lysosome-associated membrane protein.
    Jiang DB; Sun YJ; Cheng LF; Zhang GF; Dong C; Jin BQ; Song CJ; Ma Y; Zhang FL; Yang K
    Vaccine; 2015 Jun; 33(29):3367-76. PubMed ID: 26027907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the immune response elicited by vaccination with viral vectors encoding FMDV capsid proteins and boosted with inactivated virus.
    Romanutti C; D'Antuono A; Palacios C; Quattrocchi V; Zamorano P; La Torre J; Mattion N
    Vet Microbiol; 2013 Aug; 165(3-4):333-40. PubMed ID: 23683999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates.
    Kwilas S; Kishimori JM; Josleyn M; Jerke K; Ballantyne J; Royals M; Hooper JW
    Curr Gene Ther; 2014; 14(3):200-10. PubMed ID: 24867065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent approaches in hantavirus vaccine development.
    Maes P; Clement J; Van Ranst M
    Expert Rev Vaccines; 2009 Jan; 8(1):67-76. PubMed ID: 19093774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
    Hooper JW; Josleyn M; Ballantyne J; Brocato R
    Vaccine; 2013 Sep; 31(40):4314-21. PubMed ID: 23892100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro and in vivo activity of ribavirin against Andes virus infection.
    Safronetz D; Haddock E; Feldmann F; Ebihara H; Feldmann H
    PLoS One; 2011; 6(8):e23560. PubMed ID: 21853152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. First human isolate of Hantavirus (Andes virus) in the Americas.
    Galeno H; Mora J; Villagra E; Fernandez J; Hernandez J; Mertz GJ; Ramirez E
    Emerg Infect Dis; 2002 Jul; 8(7):657-61. PubMed ID: 12095430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Andes virus regulation of cellular microRNAs contributes to hantavirus-induced endothelial cell permeability.
    Pepini T; Gorbunova EE; Gavrilovskaya IN; Mackow JE; Mackow ER
    J Virol; 2010 Nov; 84(22):11929-36. PubMed ID: 20844033
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hantavirus-induced immunity in rodent reservoirs and humans.
    Schönrich G; Rang A; Lütteke N; Raftery MJ; Charbonnel N; Ulrich RG
    Immunol Rev; 2008 Oct; 225():163-89. PubMed ID: 18837782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters.
    Wahl-Jensen V; Chapman J; Asher L; Fisher R; Zimmerman M; Larsen T; Hooper JW
    J Virol; 2007 Jul; 81(14):7449-62. PubMed ID: 17475651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant DNA vaccine of Hantavirus Gn and LAMP1 induced long-term immune protection in mice.
    Jiang DB; Sun LJ; Cheng LF; Zhang JP; Xiao SB; Sun YJ; Yang SY; Wang J; Zhang FL; Yang K
    Antiviral Res; 2017 Feb; 138():32-39. PubMed ID: 27923570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sensitivity of Andes hantavirus to antiviral effect of human saliva.
    Hardestam J; Lundkvist A; Klingström J
    Emerg Infect Dis; 2009 Jul; 15(7):1140-2. PubMed ID: 19624946
    [No Abstract]   [Full Text] [Related]  

  • 54. A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice.
    Lee BH; Yoshimatsu K; Araki K; Okumura M; Nakamura I; Arikawa J
    Vaccine; 2006 Apr; 24(15):2928-34. PubMed ID: 16426712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modification of the adenoviral transfer vector enhances expression of the Hantavirus fusion protein GnS0.7 and induces a strong immune response in C57BL/6 mice.
    Li PY; Yu L; Wu XA; Bai WT; Li K; Wang HT; Hu G; Zhang L; Zhang FL; Xu ZK
    J Virol Methods; 2012 Jan; 179(1):90-6. PubMed ID: 22015676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccines against hantaviruses.
    Hjelle B
    Expert Rev Vaccines; 2002 Oct; 1(3):373-84. PubMed ID: 12901576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies.
    Engdahl TB; Binshtein E; Brocato RL; Kuzmina NA; Principe LM; Kwilas SA; Kim RK; Chapman NS; Porter MS; Guardado-Calvo P; Rey FA; Handal LS; Diaz SM; Zagol-Ikapitte IA; Tran MH; McDonald WH; Meiler J; Reidy JX; Trivette A; Bukreyev A; Hooper JW; Crowe JE
    Elife; 2023 Mar; 12():. PubMed ID: 36971354
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge.
    Ulrich R; Koletzki D; Lachmann S; Lundkvist A; Zankl A; Kazaks A; Kurth A; Gelderblom HR; Borisova G; Meisel H; Krüger DH
    J Biotechnol; 1999 Aug; 73(2-3):141-53. PubMed ID: 10486924
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques.
    Feng Y; Li C; Hu P; Wang Q; Zheng X; Zhao Y; Shi Y; Yang S; Yi C; Feng Y; Wu C; Qu L; Xu W; Li Y; Sun C; Gao FG; Xia X; Feng L; Chen L
    Emerg Microbes Infect; 2018 Jun; 7(1):101. PubMed ID: 29872043
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
    Matassov D; Marzi A; Latham T; Xu R; Ota-Setlik A; Feldmann F; Geisbert JB; Mire CE; Hamm S; Nowak B; Egan MA; Geisbert TW; Eldridge JH; Feldmann H; Clarke DK
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S443-51. PubMed ID: 26109675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.